(Q36138195)

12 August 2017

1 reference

title

Class 3 semaphorin signaling: the end of a dogma (English)

1 reference

12 August 2017

Vincent Potiron

1

1 reference

PubMed ID

15914725

12 August 2017

Joëlle Roche

series ordinal

2

1 reference

PubMed ID

15914725

12 August 2017

language of work or name

1 reference

24 May 2005

1 reference

Science's STKE : signal transduction knowledge environment

12 August 2017

1 reference

12 August 2017

2005

1 reference

12 August 2017

285

1 reference

12 August 2017

pe24

1 reference

Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins

12 August 2017

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Unified nomenclature for the semaphorins/collapsins. Semaphorin Nomenclature Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Signalling by semaphorin receptors: cell guidance and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Identification of CD72 as a Lymphocyte Receptor for the Class IV Semaphorin CD100

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Semaphorins in interactions between T cells and antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Interplay between scatter factor receptors and B plexins controls invasive growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

The semaphorin 4D receptor controls invasive growth by coupling with Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Sema4D induces angiogenesis through Met recruitment by Plexin B1

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Integrin activation by R-ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Plexin C1 engagement on mouse dendritic cells by viral semaphorin A39R induces actin cytoskeleton rearrangement and inhibits integrin-mediated adhesion and chemokine-induced migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Involvement of Fes/Fps tyrosine kinase in semaphorin3A signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Diverse gene expression and function of semaphorins in developing lung: positive and negative regulatory roles of semaphorins in lung branching morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Semaphorin-3F is an inhibitor of tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

Plexin-B3 is a functional receptor for semaphorin 5A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2852005PE24

21 January 2018

Identifiers

DOI

10.1126/STKE.2852005PE24

1 reference

12 August 2017

1 reference

PubMed ID

15914725